Developing new therapies using oligonucleotides for neurological disorders
THERAPEUTIC OLIGONUCLEOTIDE PLATFORM BIOLOGICS CHEMISTRY, MANUFACTURING AND CONTROLS (CMC), SUBJECT MATTER EXPERT CONSULTING SERVICES.
This study is working on improving new treatments made from tiny pieces of DNA or RNA for people with very rare neurological conditions, with the help of an expert to make sure these therapies are safe and effective.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Project ID | NIH-11199869 on NIH RePORTER |
What this research studies
This research focuses on enhancing the development of biological therapies, specifically therapeutic oligonucleotides, which are short DNA or RNA molecules used to treat various neurological conditions. A senior-level consultant will provide expert guidance on the chemistry, manufacturing, and controls necessary for creating these biologics. The goal is to improve the processes involved in developing gene therapies for ultra-rare neurological disorders, ensuring they are safe and effective for patients. This initiative is part of a broader effort to advance neurotherapeutics through collaboration and expert consultation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with ultra-rare neurological disorders that may benefit from gene therapy.
Not a fit: Patients with common neurological conditions or those not eligible for gene therapy may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients with rare neurological disorders.
How similar studies have performed: Previous research has shown promise in developing oligonucleotide therapies for various conditions, indicating a potential for success in this area.
Where this research is happening
Cincinnati, United States
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.